Literature DB >> 8370688

Expression of steroidogenic enzyme messenger ribonucleic acids and corticosteroid production in aldosterone-producing and "nonfunctioning" adrenal adenomas.

K Rácz1, F Pinet, T Marton, B Szende, E Gláz, P Corvol.   

Abstract

"Nonfunctioning" adrenal adenomas are often diagnosed in patients without recognizable clinical symptoms of adrenocortical hyperfunction. The objective of this study was to determine directly the steroidogenic activity of such adenomas (n = 12) and compare them histologically and functionally to normal human adrenals (n = 6) and aldosterone-producing adenomas (n = 15). The histological appearances of nonfunctioning and aldosterone-producing adenomas were surprisingly similar. Nonfunctioning adrenal adenomas expressed all mRNAs of P450scc, P450c17, P450c21, adrenodoxin, and adrenodoxin reductase with relative levels comparable to those found in normal adrenals. Consistent with their hormone-producing nature, these adenomas had cortisol and aldosterone contents as high as those in normal adrenal tissues, a significantly (P < 0.05) increased 17-hydroxyprogesterone content, and a disproportionally low expression of P450c21 mRNA compared to aldosterone-producing adenomas. Cells isolated from both aldosterone-producing and nonfunctioning adrenal adenomas exhibited highly ACTH-sensitive cortisol and aldosterone production, suggesting again the presence of both zona glomerulosa-like and zona fasciculata-like steroidogenesis in these adenoma tissues. These results indicate that so-called nonfunctioning adrenal adenomas are not without steroidogenic activity. Therefore, the assumption that adrenal adenomas are entirely nonfunctioning in the absence of recognizable hormonal hyperfunction may not be correct.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370688     DOI: 10.1210/jcem.77.3.8370688

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  The clinical evaluation of silent adrenal masses.

Authors:  B Ambrosi; E Passini; T Re; L Barbetta
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

2.  Leptin inhibits cortisol and corticosterone secretion in pathologic human adrenocortical cells.

Authors:  N Szücs; I Varga; C Jakab; A Patócs; E Gláz; M Tóth; R Kiss; K Rácz
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

3.  Pre-Cushing's syndrome not recognized by conventional dexamethasone suppression-tests in an adrenal "incidentaloma" patient.

Authors:  M Torlontano; M Zingrillo; L D'Aloiso; M R Ghiggi; A Di Cerbo; A Scillitani; G Petracca-Ciavarella; A Liuzzi
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256

4.  17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.

Authors:  G P Bernini; G Brogi; M S Vivaldi; G F Argenio; M Sgrò; A Moretti; A Salvetti
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

5.  Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy.

Authors:  M Tóth; K Rácz; V Adleff; I Varga; L Fütö; C Jakab; K Karlinger; R Kiss; E Gláz
Journal:  J Endocrinol Invest       Date:  2000-05       Impact factor: 4.256

6.  p53 protein and its messenger ribonucleic acid in human adrenal tumors.

Authors:  V Adleff; K Rácz; M Tóth; I Varga; A Bezzegh; E Gláz
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

Review 7.  The role of 21-hydroxylase in the pathogenesis of adrenal masses: review of the literature and focus on our own experience.

Authors:  L Barzon; P Maffei; N Sonino; C Pilon; L Baldazzi; A Balsamo; O Del Maschio; G Masi; M Trevisan; M Pacenti; F Fallo
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256

8.  Incidental pheochromocytoma presenting with sublaboratory findings in asymptomatic surrenal masses: a case report.

Authors:  Mesut Ozkaya; Mehmet Fatih Yuzbasioglu; Ertan Bulbuloglu; Sevgi Bakaris; Hafize Oksuz; Kadir Gisi; Ahmet Onder
Journal:  Cases J       Date:  2008-05-25

9.  Common genetic variants of the human steroid 21-hydroxylase gene (CYP21A2) are related to differences in circulating hormone levels.

Authors:  Márton Doleschall; Julianna Anna Szabó; Júlia Pázmándi; Ágnes Szilágyi; Klára Koncz; Henriette Farkas; Miklós Tóth; Péter Igaz; Edit Gláz; Zoltán Prohászka; Márta Korbonits; Károly Rácz; George Füst; Attila Patócs
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.